216 related articles for article (PubMed ID: 17962192)
61. A novel mode of enhancer evolution: the Tal1 stem cell enhancer recruited a MIR element to specifically boost its activity.
Smith AM; Sanchez MJ; Follows GA; Kinston S; Donaldson IJ; Green AR; Göttgens B
Genome Res; 2008 Sep; 18(9):1422-32. PubMed ID: 18687876
[TBL] [Abstract][Full Text] [Related]
62. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
Hsu HL; Wadman I; Baer R
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
[TBL] [Abstract][Full Text] [Related]
63. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
Huang S; Qiu Y; Stein RW; Brandt SJ
Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
[TBL] [Abstract][Full Text] [Related]
64. Protein-Protein Interactions Modulate the Docking-Dependent E3-Ubiquitin Ligase Activity of Carboxy-Terminus of Hsc70-Interacting Protein (CHIP).
Narayan V; Landré V; Ning J; Hernychova L; Muller P; Verma C; Walkinshaw MD; Blackburn EA; Ball KL
Mol Cell Proteomics; 2015 Nov; 14(11):2973-87. PubMed ID: 26330542
[TBL] [Abstract][Full Text] [Related]
65. The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition.
Park ST; Sun XH
J Biol Chem; 1998 Mar; 273(12):7030-7. PubMed ID: 9507011
[TBL] [Abstract][Full Text] [Related]
66. Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)-dependent window during hematopoietic stem-cell development.
Schlaeger TM; Mikkola HK; Gekas C; Helgadottir HB; Orkin SH
Blood; 2005 May; 105(10):3871-4. PubMed ID: 15677556
[TBL] [Abstract][Full Text] [Related]
67. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
Hofmann TJ; Cole MD
Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
[TBL] [Abstract][Full Text] [Related]
68. GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1).
Wang L; Jia Y; Rogers H; Wu YP; Huang S; Noguchi CT
J Biol Chem; 2012 Aug; 287(36):30157-69. PubMed ID: 22773876
[TBL] [Abstract][Full Text] [Related]
69. CHIP: a co-chaperone for degradation by the proteasome.
Edkins AL
Subcell Biochem; 2015; 78():219-42. PubMed ID: 25487024
[TBL] [Abstract][Full Text] [Related]
70. E3 ubiquitin ligase CHIP interacts with C-type lectin-like receptor CLEC-2 and promotes its ubiquitin-proteasome degradation.
Shao M; Li L; Song S; Wu W; Peng P; Yang C; Zhang M; Duan F; Jia D; Zhang J; Wu H; Zhao R; Wang L; Ruan Y; Gu J
Cell Signal; 2016 Oct; 28(10):1530-6. PubMed ID: 27443248
[TBL] [Abstract][Full Text] [Related]
71. Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction.
Lécuyer E; Larivière S; Sincennes MC; Haman A; Lahlil R; Todorova M; Tremblay M; Wilkes BC; Hoang T
J Biol Chem; 2007 Nov; 282(46):33649-33658. PubMed ID: 17878155
[TBL] [Abstract][Full Text] [Related]
72. Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis.
Gekas C; Rhodes KE; Gereige LM; Helgadottir H; Ferrari R; Kurdistani SK; Montecino-Rodriguez E; Bassel-Duby R; Olson E; Krivtsov AV; Armstrong S; Orkin SH; Pellegrini M; Mikkola HK
Blood; 2009 Apr; 113(15):3461-71. PubMed ID: 19211936
[TBL] [Abstract][Full Text] [Related]
73. TAL1/SCL relieves the E2-2-mediated repression of VEGFR2 promoter activity.
Tanaka A; Itoh F; Itoh S; Kato M
J Biochem; 2009 Feb; 145(2):129-35. PubMed ID: 19029143
[TBL] [Abstract][Full Text] [Related]
74. SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis.
Chagraoui H; Kassouf M; Banerjee S; Goardon N; Clark K; Atzberger A; Pearce AC; Skoda RC; Ferguson DJ; Watson SP; Vyas P; Porcher C
Blood; 2011 Jul; 118(3):723-35. PubMed ID: 21596846
[TBL] [Abstract][Full Text] [Related]
75. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
[TBL] [Abstract][Full Text] [Related]
76. Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.
Correia NC; Arcangeli ML; Pflumio F; Barata JT
Leukemia; 2016 Oct; 30(10):1968-1978. PubMed ID: 27443261
[TBL] [Abstract][Full Text] [Related]
77. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
Ono Y; Fukuhara N; Yoshie O
J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
[TBL] [Abstract][Full Text] [Related]
78. Accelerated Notch-dependent degradation of E47 proteins in aged B cell precursors is associated with increased ERK MAPK activation.
King AM; Van der Put E; Blomberg BB; Riley RL
J Immunol; 2007 Mar; 178(6):3521-9. PubMed ID: 17339447
[TBL] [Abstract][Full Text] [Related]
79. CHIP functions an E3 ubiquitin ligase of Runx1.
Shang Y; Zhao X; Xu X; Xin H; Li X; Zhai Y; He D; Jia B; Chen W; Chang Z
Biochem Biophys Res Commun; 2009 Aug; 386(1):242-6. PubMed ID: 19524548
[TBL] [Abstract][Full Text] [Related]
80. Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.
Cheng YF; Tong M; Edge AS
J Biol Chem; 2016 Sep; 291(40):21096-21109. PubMed ID: 27542412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
